Immunic Inc (NASDAQ:IMUX)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - IMUX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - IMUX

  • Market Cap$370.650m
  • SymbolNASDAQ:IMUX
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS4525EP1011

Company Profile

Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORĪ³t and IMU-856 targets the restoration of the intestinal barrier function.Vital Therapies Inc is a biotherapeutic company. The Company is engaged in developing a cell-based therapy targeting treatment acute forms of liver failure. Its product includes the ELAD System an extracorporeal bio-artificial liver support system.

Latest IMUX news

Currently there for this company. Visit our news hub for other news .